Karpus Management, Inc. DMAA Holdings History
Karpus Management, Inc.'s Drugs Made In America Acquisition Corp Holding Summary
As of 2025-03-31, Karpus Management, Inc. held 2.32 Mil shares of Drugs Made In America Acquisition Corp(DMAA), totaling $23.29 Mil. This investment constitutes 0.76% of their stock portfolio, and Karpus Management, Inc. now holds 6.93% of the outstanding Drugs Made In America Acquisition Corp(DMAA) stock.
The initial trade took place in 2025Q1. And since then Karpus Management, Inc. has made 1 purchases of DMAA, at an average price of $10.00, for a total of 2.32 Mil shares. Based on historical transaction data and DMAA's current price of $10.23, Karpus Management, Inc.'s estimated gain on his DMAA holdings is $534,527.82, reflecting a 2.30% gain to date.
Karpus Management, Inc. DMAA ($10.23) Holding Chart
Karpus Management, Inc. DMAA ($10.23) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
